This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Tebentafusp-tebn With LDT in Metastatic UM | MicrobiomeTrials
← Back to trials NCT06626516
Tebentafusp-tebn With LDT in Metastatic UM Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-10-15Est. Completion: 2030-10
Enrollment target: 109 participantsLocations Thomas Jefferson University, Philadelphia, Pennsylvania, United States Other microbiome trials you might be interested in Uveal Melanoma
This study seeks to better understand the liver's immune response to receiving chemotherapy agent melphalan through Perc…
Boston, United States Est. completion Dec 2027
Ciliary Body and Choroid Melanoma, Medium/Large Size Ciliary Body and Choroid Melanoma, Small Size Iris Melanoma Stage I Intraocular Melanoma Stage IIA Intraocular Melanoma Stage IIB Intraocular Melanoma Stage IIIA Intraocular Melanoma Stage IIIB Intraocular Melanoma
Stage IIIC Intraocular Melanoma
Stage I Uveal Melanoma AJCC V7
Stage II Uveal Melanoma AJCC V7
Stage III Uveal Melanoma AJCC V7
This randomized phase II trial studies how well sunitinib malate or valproic acid works in preventing high-risk uveal (e…
Philadelphia, United States Est. completion Dec 31, 2027
Advanced Solid Tumors
This study will test a Regeneron drug called REGN13089-M404-M2980 ("study drug") to see if it can help treat previously …
Multiple Locations Est. completion Mar 10, 2031